Sage Journals: Discover world-class research

Abstract

Autoimmune haemolytic anaemia due to malaria or following its treatment with artesunate is rare. A child presented with severe anaemia after being treated with artesunate for P. vivax malaria. Blood transfusion was difficult as cross-matching showed major incompatibility; group O negative blood under the cover of steroids was transfused. Oral steroids were given for six weeks. The patient made a complete recovery.

Keywords

Malaria autoimmune haemolytic anaemia artesunate

Get full access to this article

View all access options for this article.

References

Sonani

Bhatnagar

Maitrey

. Autoimmune hemolytic anemia in a patient with malaria. Asian J Transfus Sci 2013; 7: 151–152.

Segel

Lichtman

. Direct antiglobulin (“Coombs”) test-negative autoimmune haemolytic anaemia: a review. Blood Cells Mol Dis 2014; 52: 152–160.

Australian Red Cross. Delayed haemolytic transfusion reactions Alexandria, NSW: Australian Red Cross.. Available at: https://transfusion.com.au/adverse_transfusion_reactions/delayed_haemolytic_reaction.

Raffray

Receveur

Beguet

et al.

Severe delayed autoimmune haemolytic anaemia following artesunate administration in severe malaria: a case report. Malar J 2014; 13: 398–398.

Autoimmune haemolytic anaemia associated with P. vivax malaria

Abstract

Keywords

Get full access to this article

References